Literature DB >> 33707570

Four-decade trends in lymph node status of patients with vulvar squamous cell carcinoma in northern Italy.

Mario Preti1, Lauro Bucchi2, Leonardo Micheletti1, Silvana Privitera3, Monica Corazza4, Stefano Cosma1, Niccolò Gallio1, Alessandro Borghi4, Federica Bevilacqua1, Chiara Benedetto1.   

Abstract

The 4-decade (1980-2017) trends in lymph node status of patients with vulvar squamous cell carcinoma (VSCC) in a province of northern Italy were investigated. Information was collected on lymph node dissection, number of lymph nodes dissected, lymph node involvement, and number of positive lymph nodes from a series of 760 patients admitted to a tertiary referral centre for vulvar disease. The adjusted odds ratios (ORs) for lymph node involvement, for ≥ 2 positive nodes, and for a lymph node ratio ≥ 20% were estimated from multiple logistic regression models. The adjusted OR for lymph node dissection was greater in the 2000s and 2010s versus the 1980s. The adjusted OR for lymph node involvement was 1.36 (95% confidence interval (CI), 0.72-2.60) in the 1990s, 1.31 (95% CI, 0.72-2.38) in the 2000s and 1.32 (95% CI, 0.73-2.41) in the 2010s versus the 1980s. The adjusted OR for ≥ 2 positive nodes was 1.36 (95% CI, 0.68-2.72), 0.86 (95% CI, 0.44-1.65) and 0.67 (95% CI, 0.34-1.31), respectively. The adjusted OR for lymph node ratio ≥ 20% was 1.45 (95% CI, 0.62-3.43), 1.21 (95% CI, 0.54-2.72) and 0.81 (95% CI, 0.35-1.89), respectively. This stagnation indicates the need for a serious rethink of the local model for the care of VSCC.

Entities:  

Mesh:

Year:  2021        PMID: 33707570      PMCID: PMC7952703          DOI: 10.1038/s41598-021-85030-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

1.  Rationale and definition of the lateral extension of the inguinal lymphadenectomy for vulvar cancer derived from an embryological and anatomical study.

Authors:  Leonardo Micheletti; Alessandro Cesare Levi; Fabrizio Bogliatto; Mario Preti; Marco Massobrio
Journal:  J Surg Oncol       Date:  2002-09       Impact factor: 3.454

Review 2.  Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva.

Authors:  Angiolo Gadducci; Roberta Tana; Cecilia Barsotti; Maria Elena Guerrieri; Andrea Riccardo Genazzani
Journal:  Crit Rev Oncol Hematol       Date:  2011-10-19       Impact factor: 6.312

3.  Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma.

Authors:  M S Schuurman; L C G van den Einden; L F A G Massuger; L A Kiemeney; M A van der Aa; J A de Hullu
Journal:  Eur J Cancer       Date:  2013-09-03       Impact factor: 9.162

4.  Vulvovaginal Disease Education in Canadian and American Gynecology Residency Programs: A Survey of Program Directors.

Authors:  Christine Edwards; Nupur Dogra; Annet Antanrajakumar; Aparna Sarangapani; Amanda Selk
Journal:  J Low Genit Tract Dis       Date:  2018-07       Impact factor: 1.925

5.  Invasive squamous cell carcinoma of vulva: prognostic significance of clinicopathologic parameters.

Authors:  Marin Nola; Anto Blazanovic; Snjezana Dotlic; Anamarija Morovic; Ivana Tomicic; Stanko Jukic
Journal:  Croat Med J       Date:  2005-06       Impact factor: 1.351

6.  Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study).

Authors:  H D Homesley; B N Bundy; A Sedlis; E Yordan; J S Berek; A Jahshan; R Mortel
Journal:  Am J Obstet Gynecol       Date:  1991-04       Impact factor: 8.661

7.  In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978-2007-a nationwide population-based study.

Authors:  L Baandrup; A Varbo; C Munk; C Johansen; M Frisch; S K Kjaer
Journal:  Gynecol Oncol       Date:  2011-04-07       Impact factor: 5.482

8.  Histologic parameters of vulvar invasive carcinoma and lymph node metastases.

Authors:  M Preti; L Micheletti; M Barbero; B Ghiringhello; M C Valentino; P Nicolaci; M Canni; G Borgno; N Segnan; G Ronco
Journal:  J Reprod Med       Date:  1993-01       Impact factor: 0.142

9.  Experience in the management of patients older than 80 years with vulval cancer.

Authors:  Ahmed Talaat; Dirk Brinkmann; Yoodhvir Nagar; Patrick Hogston; Ghassan Khoury; Robert Woolas
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

10.  Vulval cancer incidence, mortality and survival in England: age-related trends.

Authors:  J Lai; R Elleray; A Nordin; L Hirschowitz; B Rous; C Gildea; J Poole
Journal:  BJOG       Date:  2013-10-22       Impact factor: 6.531

View more
  3 in total

Review 1.  New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors.

Authors:  Lauro Bucchi; Margherita Pizzato; Stefano Rosso; Stefano Ferretti
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639

2.  The Vulvar Immunohistochemical Panel (VIP) Project: Molecular Profiles of Vulvar Squamous Cell Carcinoma.

Authors:  Giorgia Garganese; Frediano Inzani; Simona Maria Fragomeni; Giulia Mantovani; Luigi Della Corte; Alessia Piermattei; Angela Santoro; Giuseppe Angelico; Luciano Giacò; Giacomo Corrado; Anna Fagotti; Gian Franco Zannoni; Giovanni Scambia
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639

3.  Vulvar Cancer: Facing a Rare Disease.

Authors:  Mario Preti; Denis Querleu
Journal:  Cancers (Basel)       Date:  2022-03-20       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.